Solvay to acquire U.S.-based Chemlogics, extending its oil & gas chemical solutions business

Solvay to acquire U.S.-based Chemlogics, extending its oil & gas chemical solutions business

ID: 303148

(Thomson Reuters ONE) -



+------------------------------------------------------------------------------+
|  |
|ü Acquisition highlights |
| |
| * Optimal fit with Solvay Novecare's products, technologies, customers and |
| geographies, leading to significant share of fast-growing $8 billion U.S. |
| oil & gas chemical market |
| * Fast-paced innovation model reinforcing R&D capabilities to enhance |
| competitiveness and sustainability |
|     |
|ü Financial considerations |
| |
| * Enterprise value of $1.3 billion (?1 billion), at 10.7x EBITDA and 8.7x |
| net of tax benefit |
| * Double-digit EBITDA growth business; cash and EPS accretive from year one |
| * Solvay intends to issue hybrid bonds for approximately ?1 billion to |
| further strengthen balance sheet |
|  |
|ü Strategic impact       |
| |
| * Accelerates Solvay's transformation into a group with higher growth, lower|
| capital intensity and greater returns |
| * Increases exposure to favourable U.S. energy scenario and positions for |




| future developments in emerging regions |
|  |
+------------------------------------------------------------------------------+


Brussels, October 7(th), 2013 --- As part of its ongoing transformation, Solvay
announces today that it has signed an agreement to acquire privately-held
Chemlogics for a total cash consideration of $1.345 billion. Adding the U.S.-
based company to Solvay's Novecare business unit will create a leader with an
extensive portfolio of tailored chemical solutions for the fast-growing oil &
gas market, serving stimulation, cementing, production and water management
applications.

For Solvay Novecare, this acquisition will yield significant synergies thanks to
a comprehensive offering of innovative products and technologies which enables
oilfield service players worldwide to competitively and safely extract oil and
gas while reducing water consumption. Chemlogics has shown annual double-digit
EBITDA growth over the past five years, thanks to a fast-paced innovation model
combined with a strong know-how and closeness to customers.

"This acquisition accelerates Solvay's ongoing transformation towards an
innovative chemical solution provider focused on high growth and strong margin
businesses with a more balanced geographical and market presence," said Jean-
Pierre Clamadieu, Chief Executive Officer of Solvay. "Our expansion in the
energy sector builds on our strategy to provide differentiated solutions
addressing the sustainability challenges that society faces with an increasing
number of consumers and scarce resources."

Founded in 2002 and headquartered in Paso Robles, California,
Chemlogics reported last-twelve-month sales of around $500 million and has 277
employees. The company serves the needs of the oil and gas industry's
stimulation and cementing segments. All its assets are located in the U.S. and
include three manufacturing sites with annual capacity exceeding 300 KT, eight
formulation centers and six research and technical
facilities.

Chemlogics's expertise in friction reducers, non-emulsifiers and extraction
technologies perfectly fit with Solvay Novecare's know-how in surfactants,
natural polymers and eco-friendly solvents. In addition, Chemlogics' customer
portfolio in the U.S. complements Novecare's global customer base. Together,
Novecare and Chemlogics will have a significant share of the dynamic $8 billion
U.S. oil and gas exploration and production market.

Chemlogics's enterprise value represents a multiple of 10.7x last-twelve-months
EBITDA, and 8.7x including tax benefits*. Although the acquisition will be
financed with available cash, Solvay intends to issue hybrid bonds** for
approximately ?1 billion which will further strengthen the Group's balance sheet
ahead of its refinancing of debt maturities from 2014 onwards. The acquisition
will be cash and EPS accretive in the first year.

The completion of the transaction, expected before the end of this year, is
subject to customary closing conditions, including U.S. anti-trust clearance.



* Net present value of cash tax benefit from intangibles amortization close to
c. $250 million

** The intended hybrid bonds should be deeply subordinated debt with a target
equity credit of 50 percent for rating agencies purposes



+------------------------------------------------------------------------------+
|As an international chemical group, SOLVAY assists industries in finding and|
|implementing ever more responsible and value-creating solutions. The Group is|
|firmly committed to sustainable development and focused on innovation and|
|operational excellence. Solvay serves diversified markets, generating 90% of|
|its turnover in activities where it is one of the top three worldwide. The|
|group is headquartered in Brussels, employs about 29,000 people in 55 |
|countries and generated 12.4 billion euros in net sales in 2012. Solvay SA|
|SOLB.BE) is listed on Nyse Euronext in Brussels and Paris (Bloomberg: SOLB.BB|
|- Reuters: SOLBt.BR). |
+------------------------------------------------------------------------------+


Lamia Narcisse Caroline Jacobs Maria Alcon Edward Mackay GEOFFROY
Media Relations Media Relations Investor Investor RASKIN
+33 1 53 56 59 62 +32 2 264 1530 Relations Relations Investor
+32 2 264 1984 +32 2 264 3687 Relations
+32 2 264 1540





You can find here the press release in PDF:
http://hugin.info/133981/R/1733855/580625.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Solvay S.A. via Thomson Reuters ONE
[HUG#1733855]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  East Capital Explorer AB - Net Asset Value (NAV) SEK 78 per share on 30 September 2013 MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 (Xmab5574)
Bereitgestellt von Benutzer: hugin
Datum: 07.10.2013 - 07:29 Uhr
Sprache: Deutsch
News-ID 303148
Anzahl Zeichen: 8027

contact information:
Town:

Brussels



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 241 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Solvay to acquire U.S.-based Chemlogics, extending its oil & gas chemical solutions business"
steht unter der journalistisch-redaktionellen Verantwortung von

Solvay S.A. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Solvay S.A.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z